Skip to main content

Table 3 Comparison of effects of cyclosporine A and tacrolimus on blood pressure and graft function tests

From: The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients

 

Pre-transplant

1st month

3rd month

6th month

12th month

24th month

36th month

48th month

Variables

CsA (n)

60

60

60

60

60

60

56

55

Tac (n)

68

68

68

68

68

68

60

56

Systolic BP (mmHg)

CsA

127.4 ± 23.4

127.7 ± 13.6

127.0 ± 13.0

128.5 ± 15.6

127.7 ± 15.1

124.6 ± 13.8

125.0 ± 14.0

128.8 ± 18.8

Tac

122.2 ± 16.6

126.6 ± 14.5

123.9 ± 13.9

123.2 ± 15.2

126.4 ± 16.7

124.1 ± 18.3

125.9 ± 20.7

127.2 ± 17.4

Diastolic BP (mmHg)

CsA

79.1 ± 11.6

79.5 ± 8.3

79.8 ± 8.7

79.8 ± 8.9

78.0 ± 7.9

77.6 ± 9.4

75.1 ± 11.3*

75.8 ± 13.5

Tac

76.1 ± 10.0

80.1 ± 9.6*

78.5 ± 8.6

78.8 ± 9.2

77.3 ± 9.5

75.1 ± 10.9

75.3 ± 13.5

76.2 ± 12.2

Hemoglobin (g/dL)

CsA

11.59 ± 1.88

12.0 ± 1.80

12.82 ± 2.44**

12.73 ± 2.15**

12.97 ± 1.95**

12.77 ± 1.76**

12.82 ± 1.76**

12.54 ± 1.79*

Tac

11.16 ± 1.89

11.5 ± 1.51

12.91 ± 1.88**

12.67 ± 1.97**

12.96 ± 1.96**

13.11 ± 1.57**

13.22 ± 1.61**

13.2 ± 1.51**

Albumin (g/dL)

CsA

3.47 ± 0.63

3.44 ± 0.57

3.80 ± 0.48**

3.92 ± 0.43**

4.06 ± 0.31**

4.11 ± 0.39**

4.10 ± 0.34**

4.14 ± 0.31**

Tac

3.52 ± 0.64

3.76 ± 0.44*

4.07 ± 0.58**

4.06 ± 0.55**

4.15 ± 0.34**

4.20 ± 0.39**

4.21 ± 0.35**

4.22 ± 0.38**

Creatinine (mg/dL)

CsA

8.83 ± 3.2

1.33 ± 0.5

1.27 ± 0.4

1.41 ± 0.5

1.27 ± 0.4

1.37 ± 0.7

1.44 ± 0.9

1.36 ± 0.5

Tac

8.83 ± 2.5

1.32 ± 0.8

1.28 ± 0.5

1.42 ± 0.5

1.41 ± 0.6

1.39 ± 0.6

1.41 ± 0.6

1.52 ± 0.7

eGFR (mL/min/1.73 m2)

CsA

7.13 ± 3.7

63.8 ± 26.1

66.0 ± 24.3

58.9 ± 21.3

64.9 ± 19.7

62.5 ± 21.0

60.2 ± 23.5

60.8 ± 21.1

Tac

7.29 ± 3.0

69.1 ± 27.6

68.5 ± 25.2

60.6 ± 24.0q

63.9 ± 26.2

63.6 ± 26.0

63.4 ± 26.8

59.0 ± 22.9qq

  1. Data were expressed as mean ± SD. CsA cyclosporine A, Tac tacrolimus, BP blood pressure, eGFR estimated glomerular filtration rate. *p < 0.05 and **p < 0.001, compared to pre-transplant values; qp < 0.001 and qqp < 0.05, compared to post-transplant 1-month values